| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |